Armer; Thomas
Patent Applications and Registrations
Patent applications and USPTO patent grants for Armer; Thomas.The latest application filed is for "rapamycin for the treatment of lymphangioleiomyomatosis".
Company Profile
16.18.34
- Armer; Thomas - Palo Alto CA
- Armer; Thomas - Los Gatos CA
- Armer; Thomas - Los Altos CA
- Armer; Thomas - Mountain View CA
Patent Activity
| Patent | Date |
|---|---|
| Rapamycin For The Treatment Of Lymphangioleiomyomatosis App 20220054410 - Lichenstein; Henri ; et al. | 2022-02-24 |
| Rapamycin for the treatment of lymphangioleiomyomatosis Grant 11,123,289 - Lichenstein , et al. September 21, 2 | 2021-09-21 |
| Inhalable rapamycin formulation for treating age-related conditions Grant 11,103,449 - Armer , et al. August 31, 2 | 2021-08-31 |
| Inhalable Rapamycin Formulation For Treating Age-related Conditions App 20210212942 - Armer; Thomas ; et al. | 2021-07-15 |
| Ergoline Compounds And Uses Thereof App 20210115042 - Armer; Thomas ; et al. | 2021-04-22 |
| Polycyclic compounds and uses thereof Grant 10,815,235 - Armer , et al. October 27, 2 | 2020-10-27 |
| Inhalable Rapamycin Formulation For The Treatment Of Pulmonary Hypertension App 20200306230 - Armer; Thomas ; et al. | 2020-10-01 |
| Rapamycin For The Treatment Of Lymphangioleiomyomatosis App 20200276120 - Lichenstein; Henri ; et al. | 2020-09-03 |
| Ergoline compounds and uses thereof Grant 10,703,753 - Armer , et al. | 2020-07-07 |
| Ergoline Compounds And Uses Thereof App 20190337947 - Armer; Thomas ; et al. | 2019-11-07 |
| Ergoline compounds and uses thereof Grant 10,464,936 - Armer , et al. No | 2019-11-05 |
| Polycyclic Compounds And Uses Thereof App 20190233419 - Armer; Thomas ; et al. | 2019-08-01 |
| Ergoline Compounds And Uses Thereof App 20190169188 - Armer; Thomas ; et al. | 2019-06-06 |
| Ergoline compounds and uses thereof Grant 10,308,651 - Armer , et al. | 2019-06-04 |
| Rapamycin for the treatment of lymphangioleiomyomatosis Grant 10,307,371 - Armer , et al. | 2019-06-04 |
| Rapamycin for the treatment of lymphangioleiomyomatosis Grant 10,307,370 - Lichenstein , et al. | 2019-06-04 |
| Polycyclic compounds and uses thereof Grant 10,301,311 - Armer , et al. | 2019-05-28 |
| Inhalable Rapamycin Formulation For Treating Age-related Conditions App 20190133938 - Armer; Thomas ; et al. | 2019-05-09 |
| Polycyclic Compounds And Uses Thereof App 20190100521 - Armer; Thomas ; et al. | 2019-04-04 |
| Ergoline compounds and uses thereof Grant 10,246,458 - Armer , et al. | 2019-04-02 |
| Ergoline Compounds And Uses Thereof App 20180327404 - Armer; Thomas ; et al. | 2018-11-15 |
| Ergoline Compounds And Uses Thereof App 20180298001 - Armer; Thomas ; et al. | 2018-10-18 |
| Rapamycin For The Treatment Of Lymphangioleiomyomatosis App 20180200184 - Armer; Thomas ; et al. | 2018-07-19 |
| Ergoline compounds and uses thereof Grant 9,951,070 - Armer , et al. April 24, 2 | 2018-04-24 |
| Ergoline compounds and uses thereof Grant 9,938,277 - Armer , et al. April 10, 2 | 2018-04-10 |
| Isoergoline compounds and uses thereof Grant 9,815,830 - Armer , et al. November 14, 2 | 2017-11-14 |
| An Inhalable Rapamycin Formulation For The Treatment Of Pulmonary Hypertension App 20170304276 - Armer; Thomas ; et al. | 2017-10-26 |
| Isoergoline compounds and uses thereof Grant 9,777,016 - Armer , et al. October 3, 2 | 2017-10-03 |
| 8'-hydroxy-dihydroergotamine Compounds And Compositions App 20170231976 - Armer; Thomas ; et al. | 2017-08-17 |
| Isoergoline Compounds And Uses Thereof App 20170233387 - Armer; Thomas ; et al. | 2017-08-17 |
| Isoergoline Compounds And Uses Thereof App 20170233404 - Armer; Thomas ; et al. | 2017-08-17 |
| Ergoline Compounds And Uses Thereof App 20170174685 - Armer; Thomas ; et al. | 2017-06-22 |
| Ergoline Compounds And Uses Thereof App 20170174684 - Armer; Thomas ; et al. | 2017-06-22 |
| Isoergoline compounds and uses thereof Grant 9,676,776 - Armer , et al. June 13, 2 | 2017-06-13 |
| Ergoline compounds and uses thereof Grant 9,657,020 - Armer , et al. May 23, 2 | 2017-05-23 |
| An Inhalable Rapamycin Formulation for Treating Age-Related Conditions App 20170014341 - Armer; Thomas ; et al. | 2017-01-19 |
| 8'-hydroxy-dihydroergotamine Compounds And Compositions App 20160263101 - Kellerman; Donald J. ; et al. | 2016-09-15 |
| Rapamycin for the Treatment of Lymphangioleiomyomatosis App 20160235668 - Rothberg; Jonathan M. ; et al. | 2016-08-18 |
| Methods For Treating And/or Preventing Emesis And/or Nausea Including Acute And/or Delayed Nausea And/or Acute Emesis And/or Delayed Emesis App 20160206610 - ARMER; THOMAS ; et al. | 2016-07-21 |
| Ergoline Compounds And Uses Thereof App 20160207921 - ARMER; Thomas ; et al. | 2016-07-21 |
| Isoergoline Compounds And Uses Thereof App 20160207920 - ARMER; THOMAS ; et al. | 2016-07-21 |
| 8'-hydroxy-dihydroergotamine compounds and compositions Grant 9,394,314 - Kellerman , et al. July 19, 2 | 2016-07-19 |
| 8'-hydroxy-dihydroergotamine Compounds And Compositions App 20150306096 - Armer; Thomas ; et al. | 2015-10-29 |
| Inhalation devices and related methods for administration of sedative hypnotic compounds Grant 9,161,912 - Cook , et al. October 20, 2 | 2015-10-20 |
| Rapamycin For The Treatment Of Lymphangioleiomyomatosis App 20150265582 - Armer; Thomas ; et al. | 2015-09-24 |
| Novel Ergoline Derivatives And Uses Thereof App 20150238487 - Armer; Thomas ; et al. | 2015-08-27 |
| Fluoroergoline Derivatives And Uses Thereof App 20150133456 - Armer; Thomas ; et al. | 2015-05-14 |
| 8'-hydroxy-dihydroergotamine Compounds And Compositions App 20140179704 - Kellerman; Donald J. ; et al. | 2014-06-26 |
| Novel Ergoline Derivatives And Uses Thereof App 20140179707 - Armer; Thomas ; et al. | 2014-06-26 |
| Fluoroergoline Derivatives And Uses Thereof App 20140179706 - Armer; Thomas ; et al. | 2014-06-26 |
| 8'-hydroxy-dihydroergotamine Compounds And Compositions App 20140179705 - Armer; Thomas ; et al. | 2014-06-26 |
| Inhalation Devices And Related Methods For Administration Of Sedative Hypnotic Compounds App 20140023595 - Cook; Robert Owen ; et al. | 2014-01-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 